Citation data

CrossRef

Works that cite this article, indexed by Crossref.

10 resultsUpdated October 25, 2026
1

Lessons From Clinical Trials of Immunomodulatory Drugs in Psychiatric Disorders

Biological Psychiatry 99(11) (2026)

Thomas Pak; Nabila Haque; Manish K. Jha

2

Antipsychotic Effects of Celecoxib Add-On Haloperidol in Schizophrenia: A Randomized Double-Blind Placebo-Controlled Clinical Trial

Iranian Journal of Psychiatry and Behavioral Sciences 18(1) (2024)

Mehran Zarghami; Nasrin Dodangi; Paria Azari; Alireza Khalilian

4

Linking Metabolic Disorders and Immune System Phenomena in Schizophrenia: The Role of Adipose Tissue and Inflammation

Biomedicines 13(9) (2025)

Aleksandra Julia Oracz; Mateusz Zwierz; Maciej Naumowicz; Stefan Modzelewski; Maria Suprunowicz; Napoleon Waszkiewicz

5

Antithrombotic agents in the treatment of severe mental illness: A systematic review and meta-analysis of randomized controlled trials

Neuroscience & Biobehavioral Reviews 183 (2026)

Caroline Fussing Bruun; Mette Ungermann Fredskild; Maria Faurholt-Jepsen; Maj Vinberg; Lars Vedel Kessing; Klaus Munkholm

6

Anti-inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing

Clinical Psychopharmacology and Neuroscience 18(1) (2020)

Jonghee Hong; Minji Bang

7

The Role of Inflammation in the Treatment of Schizophrenia

Frontiers in Psychiatry 11 (2020)

Guillaume Fond; Christophe Lançon; Theo Korchia; Pascal Auquier; Laurent Boyer

9

Efficacy and safety of anti-inflammatory drug-assisted treatment of symptoms in patients with schizophrenia: a meta-analysis

BMC Psychiatry 26(1) (2026)

Honglian Li; Hong Shen; Xueyu Duan; Meixian Guo; Xiaobo Liu

10

Microglia and microbiome in schizophrenia: can immunomodulation improve symptoms?

Journal of Neural Transmission 130(9) (2023)

Georg Juckel; Nadja Freund